Best case scenarios;
$750m from Sarepta, no dillution. SP hits eg, $2
(570m shares ÷ $750m = $1.31 + current 31c = $1.62, plus SRPT / global exposure =$2+)
EMA approval $2+
MS trial continuation actioned asap $3
Other indications initiated asap $4
all by xmas.
Older data but interesting ..MS summary, page-16
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
